Published in Eur J Clin Invest on August 01, 1974
High levels of secretory IgA and free secretory component in the serum of rats with bile duct obstruction. J Exp Med (1978) 1.91
Selective transport of polymeric immunoglobulin A in bile. Quantitative relationships of monomeric and polymeric immunoglobulin A, immunoglobulin M, and other proteins in serum, bile, and saliva. J Clin Invest (1982) 1.84
Biochemistry of bile secretion. Biochem J (1987) 1.41
Transcytosis and paracellular movements of horseradish peroxidase across liver parenchymal tissue from blood to bile. Effects of alpha-naphthylisothiocyanate and colchicine. Biochem J (1985) 1.36
A major histocompatibility complex class I-related Fc receptor for IgG on rat hepatocytes. J Clin Invest (1995) 1.33
Sources of proteins in human bile. Gut (1985) 1.21
Biliary protein output by isolated perfused rat livers. Effects of bile salts. Biochem J (1983) 1.20
Enzymes and proteins in bile. Variations in output in rat cannula bile during and after depletion of the bile-salt pool. Biochem J (1981) 1.17
Receptor-mediated biliary transport of immunoglobulin A and asialoglycoprotein: sorting and missorting of ligands revealed by two radiolabeling methods. J Cell Biol (1984) 1.15
The role of the Brambell receptor (FcRB) in liver: protection of endocytosed immunoglobulin G (IgG) from catabolism in hepatocytes rather than transport of IgG to bile. Immunology (2000) 1.09
1-Naphthylisothiocyanate-induced permeability of hepatic tight junctions to proteins. Biochem J (1986) 1.07
Studies on the mechanisms of biliary excretion of circulating glycoproteins. The carcinoembryonic antigen. Biochem J (1980) 1.07
Demonstration of IgA and secretory component in human hepatocytes. Gut (1980) 1.05
A polymeric IgA response in serum can be produced by parenteral immunization. Immunology (1987) 1.05
Abnormal secretion of proteins into bile from colchicine-treated isolated perfused rat livers. Biochem J (1983) 0.99
Formation of lipoprotein-X. Its relationship to bile compounds. J Clin Invest (1976) 0.96
Effects of colchicine and vinblastine on output of proteins into bile. Biochem J (1982) 0.95
Appearance of IgG and IgA antibodies in human bile after tetanus toxoid immunization. Clin Exp Immunol (1989) 0.94
Gall bladder: the predominant source of bile IgA in man? Clin Exp Immunol (1985) 0.88
A search for an enriched source of polymeric IgA in human thoracic duct lymph, portal vein blood and aortic blood. Clin Exp Immunol (1982) 0.84
Effects of percutaneous transhepatic biliary drainage on blood-bile permeability and selective IgA transport in patients with biliary obstructions. Ann Surg (1990) 0.77
A comparison of IgA in portal and peripheral venous blood. Immunology (1987) 0.75
Total protein output during rapid reduction of bile salt secretion rates in man. Gut (1989) 0.75
Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry (1965) 96.68
Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J Exp Med (1969) 5.12
The distribution of immunoglobulin-containing cells along the human gastrointestinal tract. Gastroenterology (1966) 3.98
Antibodies of the IgA type in intestinal plasma cells of germfree mice after oral or parenteral immunization with ferritin. J Exp Med (1969) 3.79
Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J (1993) 3.75
Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature (1991) 3.61
The normal microbial flora as a major stimulus for proliferation of plasma cells synthesizing IgA in the gut. The germ-free intestinal tract. Int Arch Allergy Appl Immunol (1968) 3.33
Association of lactoferrin with specific granules in rabbit heterophil leukocytes. J Exp Med (1970) 3.32
Cell damage-induced conformational changes of the pro-apoptotic protein Bak in vivo precede the onset of apoptosis. J Cell Biol (1999) 3.18
Metal-combining properties of human lactoferrin (red milk protein). 1. The involvement of bicarbonate in the reaction. Eur J Biochem (1968) 2.80
The involvement of lactoferrin in the hyposideremia of acute inflammation. J Exp Med (1974) 2.75
A mechanism for the induction of immunological tolerance by antigen feeding: antigen-antibody complexes. J Exp Med (1975) 2.59
Molecular weight, single-chain structure and amino acid composition of human lactoferrin. Eur J Biochem (1971) 2.47
Immunohistochemical observations on lymphoid tissues from conventional and germ-free mice. Lab Invest (1970) 2.45
IgA subclasses in various secretions and in serum. Immunology (1982) 2.43
Immunohistochemical localization and bacteriostatic properties of an iron-binding protein from bronchial mucus. Thorax (1966) 2.42
Glutaraldehyde-activated aminohexyl- derivative of Sepharose 4B as a new verstile immunoabsorbent. Immunochemistry (1975) 2.42
Transplantable immunoglobulin-secreting tumours in rats. IV. Sixty-three IgE-secreting immunocytoma tumours. Immunology (1974) 2.36
Detection of circulating antigen-antibody complexes by their inhibitory effect on the agglutination of IgG-coated particles by rheumatioid factor of Clq. Clin Exp Immunol (1976) 2.00
Lack of gamma A-immunoglobulin in serum of patients with steatorrhoea. Gut (1966) 1.97
Mesenteric lymph as a major source of serum IgA in guinea pigs and rats. Eur J Immunol (1973) 1.90
Changes in size, subclass, and metabolic properties of serum immunoglobulin A in liver diseases and in other diseases with high serum immunoglobulin A. J Clin Invest (1983) 1.86
Influence of repeated administration of antigen by the oral route on specific antibody-producing cells in the mouse spleen. Digestion (1973) 1.84
Selective transport of polymeric immunoglobulin A in bile. Quantitative relationships of monomeric and polymeric immunoglobulin A, immunoglobulin M, and other proteins in serum, bile, and saliva. J Clin Invest (1982) 1.84
Lactoferrin in milk from different species. Comp Biochem Physiol B (1971) 1.82
'Fit-for-purpose' validation of SearchLight multiplex ELISAs of angiogenesis for clinical trial use. J Immunol Methods (2009) 1.81
Requirement of basement membrane for the suppression of programmed cell death in mammary epithelium. J Cell Sci (1996) 1.80
Subclasses of human immunoglobulin a based on differences in the alpha polypeptide chains. Science (1966) 1.79
Origin and molecular size of immunoglobulin-A in the mesenteric lymph of the dog. Immunology (1970) 1.78
Biomarkers of angiogenesis and their role in the development of VEGF inhibitors. Br J Cancer (2009) 1.78
Epigenetic determinants of resistance to etoposide regulation of Bcl-X(L) and Bax by tumor microenvironmental factors. J Natl Cancer Inst (2000) 1.77
Interference of oral immunization with the intestinal absorption of heterologous albumin. Eur J Immunol (1974) 1.74
Further studies on single radial immunodiffusion. II. The reversed system: diffusion of antibodies in antigen-containing gels. Immunochemistry (1969) 1.68
Transplantable immunoglobulin-secreting tumours in rats. I. General features of LOU-Ws1 strain rat immunocytomas and their monoclonal proteins. Int J Cancer (1972) 1.66
Studies on the proteins of human saliva. Biochim Biophys Acta (1965) 1.65
Selective IgA deficiency with steatorrhea. A new syndrome. Am J Med (1967) 1.63
bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways. Cancer Res (1993) 1.59
Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study. Br J Cancer (2009) 1.50
A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. Br J Cancer (2011) 1.50
Apoptosis and cancer chemotherapy. Trends Cell Biol (2001) 1.48
Secretion of immunoglobulins and plasma proteins from the jejunal mucosa. Transport rate and origin of polymeric immunoglobulin A. J Clin Invest (1984) 1.44
Biomarker method validation in anticancer drug development. Br J Pharmacol (2007) 1.41
Studies on the proteins of human bronchial secretions. Biochim Biophys Acta (1965) 1.39
Origin and nature of the proteins of bile. II. A comparative analysis of serum, hepatic lymph and bile proteins in the dog. Eur J Clin Invest (1974) 1.38
Thirty cases of monoclonal immunoglobulin disorders other than myeloma or macroglobulinemia. A classification of diseases associated with the production of monoclonal-type immunoglobulins. Am J Med (1969) 1.38
Validation of pharmacodynamic assays to evaluate the clinical efficacy of an antisense compound (AEG 35156) targeted to the X-linked inhibitor of apoptosis protein XIAP. Br J Cancer (2005) 1.36
A possible homologue of mammalian IgA in chicken serum and secretions. Immunology (1972) 1.35
Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii. Dig Dis Sci (1990) 1.34
Optimisation of circulating biomarkers of cell death for routine clinical use. Ann Oncol (2008) 1.32
Damage-induced Bax N-terminal change, translocation to mitochondria and formation of Bax dimers/complexes occur regardless of cell fate. EMBO J (2001) 1.32
The metabolism of different immunoglobulin classes in irradiated mice. V. Contribution of the gut to serum IgA levels in normal and irradiated mice. Immunology (1971) 1.31
Proapoptotic Bid binds to monolysocardiolipin, a new molecular connection between mitochondrial membranes and cell death. Cell Death Differ (2003) 1.27
PCAF is an HIF-1alpha cofactor that regulates p53 transcriptional activity in hypoxia. Oncogene (2008) 1.26
Extracellular matrix regulates apoptosis in mammary epithelium through a control on insulin signaling. J Cell Biol (1999) 1.24
Cellular damage signals promote sequential changes at the N-terminus and BH-1 domain of the pro-apoptotic protein Bak. Oncogene (2001) 1.23
Distribution of alpha-chain subclasses in normal and pathological IgA-globulins. Immunology (1968) 1.23
Immunoglobulin levels in cord-blood serum of negroes and Caucasians. Trop Geogr Med (1966) 1.23
Immunoglobulin formation and function in different tissues. Curr Top Microbiol Immunol (1968) 1.20
Immunohistochemical localization of the iron-binding protein lactoferrin in human bronchial glands. Experientia (1965) 1.20
Effects of cisplatin on the induction of apoptosis in proliferating hepatoma cells and nonproliferating immature thymocytes. Cancer Res (1993) 1.20
Electrophoretic morphology of gamma globulins in cerebrospinal fluid of multiple sclerosis and other diseases of the nervous system. Neurology (1970) 1.19
Qualification of M30 and M65 ELISAs as surrogate biomarkers of cell death: long term antigen stability in cancer patient plasma. Cancer Chemother Pharmacol (2007) 1.19
Activated c-SRC in ductal carcinoma in situ correlates with high tumour grade, high proliferation and HER2 positivity. Br J Cancer (2006) 1.18
Reactivating HIF prolyl hydroxylases under hypoxia results in metabolic catastrophe and cell death. Oncogene (2009) 1.17
Biological significance of exocrine gamma-A-immunoglobulin. Acta Med Scand Suppl (1966) 1.17
Cisplatin- and paclitaxel-induced apoptosis of ovarian carcinoma cells and the relationship between bax and bak up-regulation and the functional status of p53. Mol Pharmacol (1998) 1.17
Characterization of cell volume loss in CEM-C7A cells during dexamethasone-induced apoptosis. Am J Physiol (1996) 1.15
Bid, a widely expressed proapoptotic protein of the Bcl-2 family, displays lipid transfer activity. Mol Cell Biol (2001) 1.13
Current status and future potential of somatic mutation testing from circulating free DNA in patients with solid tumours. Hugo J (2011) 1.13
Transplantable immunoglobulin-secreting tumours in rats. Purification and chemical characterization of four kappa chains from LOU-Wsl rats. Eur J Biochem (1972) 1.11
[Immunological responses to oraly ingested antigens (author's transl)]. Ann Immunol (Paris) (1973) 1.09
Studies on the IgA system of the horse. Immunology (1971) 1.09
Communications. Identification of IgA in several mammalian species. J Immunol (1969) 1.08
Fit-for-purpose biomarker method validation for application in clinical trials of anticancer drugs. Br J Cancer (2010) 1.08
Identification of J-chain in polymeric immunoglobulins from a variety of species by cross-reaction with rabbit antisera to human J-chain. J Immunol (1973) 1.07
Liver damage caused by therapeutic vitamin A administration: estimate of dose-related toxicity in 41 cases. Gastroenterology (1991) 1.07
The metabolism of different immunoglobulin classes in irradiated mice. II. Role of the gut. Immunology (1970) 1.06
Distribution in human nasopharyngeal tonsils of plasma cells containing different types of immunoglobulin polypeptide chains. Lab Invest (1967) 1.06
Antibodies induced by local antigenic stimulation of mucosal surfaces. Ann N Y Acad Sci (1971) 1.05
Comparative molecular size of mouse IgA in different body fluids. Int Arch Allergy Appl Immunol (1970) 1.05
Nude mouse embryo: ectodermal nature of the primordial thymic defect. Scand J Immunol (1975) 1.05
Dynamic CT in pancreatic lymphoma. J Comput Assist Tomogr (1993) 1.04
Cisplatin, camptothecin, and taxol sensitivities of cells with p53-associated multidrug resistance. Mol Pharmacol (1996) 1.03
Identification and some properties of rat secretory component. J Immunol (1975) 1.02
Breath 14CO2 after intravenous administration of [14C]aminopyrine in liver diseases. Dig Dis Sci (1982) 1.02
The liver in the IgA secretory immune system. Dogs, but not rats and rabbits, are suitable models for human studies. Hepatology (1983) 1.01
Presence of an Iron-binding protein (lactoferrin) in the genital tract of the human female. I. Its immunohistochemical localization in the endometrium. Fertil Steril (1968) 1.01
Biomarkers of apoptosis. Br J Cancer (2008) 1.01
Identification of IgA in rat serum and secretions. J Immunol (1969) 1.01
Distribution of various immunoglobulin containing cells in canine lymphoid tissue. Immunology (1969) 1.01
Clinical importance of the biochemical changes in the female genital tract. I. Studies on the proteins of cervical mucus. Int J Fertil (1969) 1.00
Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphoma. Br J Cancer (2011) 1.00
Jejunal immunoglobulin and antigliadin antibody secretion in adult coeliac disease. Gut (1990) 1.00
The immunoglobulins of the dog. II. The immunoglobulins of canine secretions. Immunochemistry (1969) 0.99
Sequential immunofluorescent staining: a simple and useful technique. Immunology (1969) 0.99
Metal-combining properties of human lactoferrin. The possible involvement of tyrosyl residues in the binding sites. Spectrophotometric titration. Eur J Biochem (1972) 0.98
The IgA system of the guinea pig. J Immunol (1972) 0.98
IAPs as a target for anticancer therapy. Curr Cancer Drug Targets (2007) 0.98